MetroHealth forms its Center for Cancer Research, dedicated to delivering cutting-edge care to everyone

From MetroHealth: Bingcheng Wang, PhD (pictured), Director of the Division of Cancer Biology in the Department of Medicine and Director of Basic Sciences in the MetroHealth Research Institute, has assembled an impressive team of cancer researchers who are bringing cutting-edge care to The MetroHealth System and its hundreds of thousands of patients.

William Tse, MD, is training blood cells to become cancer-killing CAR T cells so patients can beat cancer without the toxic side effects of chemotherapy and radiation. Khalid Sossey-Alaoui, PhD, is working to understand why triple-negative breast cancer occurs much more often in African-American women so he can help end the dreaded disease. Zhisan Wang, MD, PhD, is searching for the biological signal in patients’ bodies that tell doctors lung cancer is there – long before it becomes deadly.

They are four of eight nationally and internationally recognized researchers forming a new cancer research team in Cleveland focused on more than curing one of the most feared diseases. The team, which is backed by millions of dollars in support and grants and dozens of research assistants, will also focus on ending the racial, ethnic, social and economic inequities that impact cancer diagnosis and treatment.

Read the full release